5:49 PM EDT, April 23, 2014
NEW YORK (Reuters) - U.S. stocks dipped on Wednesday to snap a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.
Biotech shares pulled the Nasdaq lower. Amgen Inc
"You've got some big numbers coming out from companies that have already been pretty volatile in the Nasdaq, and there is some caution against the potential for shortfalls that could restart Nasdaq on the way down," said Rick Meckler, president of LibertyView Capital Management in Jersey City, New Jersey.
"This is traditionally not going to be a particularly strong time for earnings reports, and it's easy to take less inspiring numbers and say this market is overvalued or pass them by and say this is a seasonally low point. So it really is more about investors' own view of how high a multiple they are willing to pay."
There were bright spots within biotech. Gilead Sciences Inc
The Dow Jones industrial average <.DJI> fell 12.72 points or 0.08 percent, to end at 16,501.65. The S&P 500 <.SPX> lost 4.16 points or 0.22 percent, to 1,875.39. The Nasdaq Composite <.IXIC> dropped 34.491 points or 0.83 percent, to 4,126.967.
After the closing bell, Apple Inc jumped 7.3 percent to $563 after the iPhone maker reported quarterly results, approved a seven-for-one stock split and expanded its share-buyback authorization by $30 billion.
In another big move after the close, Facebook Inc
Better-than-expected earnings have buoyed Wall Street lately, though companies have largely been beating reduced forecasts. Profits are seen rising 1.6 percent this quarter, down from the 6.5 percent growth rate estimated at the start of the year, according to Thomson Reuters data.
Of the 141 companies in the S&P 500 that had posted results through Wednesday morning, 65.2 percent have topped expectations, above the long-term average of 63 percent. On the revenue side, 53.6 percent have exceeded forecasts, below the 61 percent long-term average.
Procter & Gamble Co's
New home sales tumbled more than expected to an eight-month low in March. The PHLX housing sector index <.HGX> fell 1.1 percent, with D.R. Horton Inc
Volume was light, with about 5.67 billion shares traded on U.S. exchanges, well below the 6.65 billion average so far this month, according to BATS Global Markets.
Declining stocks outnumbered advancing ones on the NYSE by 1,566 to 1,482, while on the Nasdaq, decliners beat advancers by 1,775 to 819.
(Editing by Nick Zieminski and Jan Paschal)
Copyright © 2014, Reuters